Earnings · US stocks
Nektar Therapeutics (NKTR) earnings
Nektar Therapeutics published its quarterly report on 2026-11-12. The stock moved -3.60% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-12
- Result
- Bad / loss
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.05% | — |
| 3 days | -3.60% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 6 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +4.46%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-12 | -1.63 | +21.23% | -3.60% | — | — |
| 2026-08-13 | -1.21 | +40.54% | -3.00% | -24.84% | -24.00% |
| 2026-05-07 | -1.78 | -20.47% | -5.93% | -21.19% | -22.95% |
| 2026-03-12 | -1.29 | +63.10% | +6.68% | +30.30% | +23.11% |
| 2025-11-06 | -1.87 | +33.03% | +7.51% | -15.02% | -16.56% |
| 2025-08-07 | -2.78 | +10.89% | +8.51% | +153.52% | +148.54% |
| 2025-05-08 | -3.61 | -27.71% | +14.52% | -93.16% | -99.37% |
| 2025-03-12 | -2.25 | +23.08% | +10.98% | -9.76% | -7.58% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.